• 18 Hits
  • Search Condition : Filter (MeSH = Colorectal Neoplasms / drug therapy*)
Species Resource Title
Human and Animal Cells HCT116(RCB2979) In Vitro and In Silico Study of Analogs of Plant Product Plastoquinone to Be Effective in Colorectal Cancer Treatment.
Human and Animal Cells JLS-V9(RCB2651) Stromal reaction inhibitor and immune-checkpoint inhibitor combination therapy attenuates excluded-type colorectal cancer in a mouse model.
Human and Animal Cells HF19(RCB0210) Synthesis, docking, cytotoxicity, and LTA4H inhibitory activity of new gingerol derivatives as potential colorectal cancer therapy.
Human and Animal Cells Ehrlich(RCB0142) Chemical and molecular bases of dome formation in human colorectal cancer cells mediated by sulphur compounds from Cucumis melo var. conomon.
Human and Animal Cells CACO-2(RCB0988) Low‑dose trametinib and Bcl‑xL antagonist have a specific antitumor effect in KRAS‑mutated colorectal cancer cells.
Human and Animal Cells COLO205(RCB2127) , JHCOLOYI(RCB1706) , PMF-ko14(RCB1426) EGFR Downregulation after Anti-EGFR Therapy Predicts the Antitumor Effect in Colorectal Cancer.
Human and Animal Cells CACO-2(RCB0988) Augmented pentose phosphate pathway plays critical roles in colorectal carcinomas.
Human and Animal Cells CHO-K1 Significant antitumor effect of an antibody against TMEM180, a new colorectal cancer-specific molecule.
Human and Animal Cells Sa3(RCB0980) , LU65(RCB1967) Phosphorylated vimentin as an immunotherapeutic target against metastatic colorectal cancer.
Human and Animal Cells 293T(RCB2202) Upregulation of nuclear factor (erythroid-derived 2)-like 2 protein level in the human colorectal adenocarcinoma cell line DLD-1 by a heterocyclic organobismuth(III) compound: Effect of organobismuth(III) compound on NRF2 signaling.
Human and Animal Cells HCT116(RCB2979) Rabeprazole intake does not affect systemic exposure to capecitabine and its metabolites, 5'-deoxy-5-fluorocytidine, 5'-deoxy-5-fluorouridine, and 5-fluorouracil.
Human and Animal Cells PANC-1(RCB2095) The G2 checkpoint inhibitor CBP-93872 increases the sensitivity of colorectal and pancreatic cancer cells to chemotherapy.
Human and Animal Cells CACO-2(RCB0988) Phosphorylated retinoblastoma protein is a potential predictive marker of irinotecan efficacy for colorectal cancer.
Human and Animal Cells CW-2(RCB0778) Heterogeneous EGFR gene copy number increase is common in colorectal cancer and defines response to anti-EGFR therapy.
Human and Animal Cells LoVo(RCB1639) , COLO-320(RCB1193) Statins inhibit tumor progression via an enhancer of zeste homolog 2-mediated epigenetic alteration in colorectal cancer.
Human and Animal Cells MKN74(RCB1002) Efficacy of Combination Chemotherapy Using a Novel Oral Chemotherapeutic Agent, TAS-102, with Oxaliplatin on Human Colorectal and Gastric Cancer Xenografts.
DNA material CSII-EF-MCS (RDB04378) RFPL4A increases the G1 population and decreases sensitivity to chemotherapy in human colorectal cancer cells.
Human and Animal Cells MKN74(RCB1002) In vitro evaluation of histone deacetylase inhibitors as combination agents for colorectal cancer.